These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 2171704)
1. Decreased concentration of 1,25-dihydroxyvitamin D3 receptors in peripheral mononuclear cells of patients with X-linked hypophosphatemic rickets: effect of phosphate supplementation. Nakajima S; Yamaoka K; Yamamoto T; Okada S; Tanaka H; Seino Y Bone Miner; 1990 Sep; 10(3):201-9. PubMed ID: 2171704 [TBL] [Abstract][Full Text] [Related]
2. Effect of single oral phosphate loading on vitamin D metabolites in normal subjects and in X-linked hypophosphatemic rickets. Yamaoka K; Tanaka H; Kurose H; Shima M; Ozono K; Nakajima S; Seino Y Bone Miner; 1989 Sep; 7(2):159-69. PubMed ID: 2804451 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia. Drezner MK; Lyles KW; Haussler MR; Harrelson JM J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520 [TBL] [Abstract][Full Text] [Related]
4. 24,25 Dihydroxyvitamin D supplementation corrects hyperparathyroidism and improves skeletal abnormalities in X-linked hypophosphatemic rickets--a clinical research center study. Carpenter TO; Keller M; Schwartz D; Mitnick M; Smith C; Ellison A; Carey D; Comite F; Horst R; Travers R; Glorieux FH; Gundberg CM; Poole AR; Insogna KL J Clin Endocrinol Metab; 1996 Jun; 81(6):2381-8. PubMed ID: 8964881 [TBL] [Abstract][Full Text] [Related]
5. Parathyroid hormone effects on serum 1,25-dihydroxyvitamin D levels in patients with X-linked hypophosphatemic rickets: evidence for abnormal 25-hydroxyvitamin D-1-hydroxylase activity. Lyles KW; Drezner MK J Clin Endocrinol Metab; 1982 Mar; 54(3):638-44. PubMed ID: 6276432 [TBL] [Abstract][Full Text] [Related]
6. A prospective trial of phosphate and 1,25-dihydroxyvitamin D3 therapy in symptomatic adults with X-linked hypophosphatemic rickets. Sullivan W; Carpenter T; Glorieux F; Travers R; Insogna K J Clin Endocrinol Metab; 1992 Sep; 75(3):879-85. PubMed ID: 1517380 [TBL] [Abstract][Full Text] [Related]
7. Effect of dipyridamole on serum and urinary phosphate in X-linked hypophosphatemia. Seikaly MG; Quigley R; Baum M Pediatr Nephrol; 2000 Nov; 15(1-2):57-9. PubMed ID: 11095012 [TBL] [Abstract][Full Text] [Related]
8. 1,25-Dihydroxyvitamin D3 does not up-regulate vitamin D receptor messenger ribonucleic acid levels in hypophosphatemic mice. Nakajima S; Yamaoka K; Okada S; Pike JW; Seino Y; Haussler MR Bone Miner; 1992 Dec; 19(3):201-13. PubMed ID: 1335319 [TBL] [Abstract][Full Text] [Related]
9. The concurrence of hypoparathyroidism provides new insights to the pathophysiology of X-linked hypophosphatemic rickets. Lyles KW; Burkes EJ; McNamara CR; Harrelson JM; Pickett JP; Drezner MK J Clin Endocrinol Metab; 1985 Apr; 60(4):711-7. PubMed ID: 4038714 [TBL] [Abstract][Full Text] [Related]
10. Serum 1,25-dihydroxyvitamin D levels in normal subjects and in patients with hereditary rickets or bone disease. Scriver CR; Reade TM; DeLuca HF; Hamstra AJ N Engl J Med; 1978 Nov; 299(18):976-9. PubMed ID: 308618 [TBL] [Abstract][Full Text] [Related]
12. X-linked hypophosphatemic rickets: a study (with literature review) of linear growth response to calcitriol and phosphate therapy. Petersen DJ; Boniface AM; Schranck FW; Rupich RC; Whyte MP J Bone Miner Res; 1992 Jun; 7(6):583-97. PubMed ID: 1414477 [TBL] [Abstract][Full Text] [Related]
13. Serum 1,25-dihydroxyvitamin D levels in subjects with X-linked hypophosphatemic rickets and osteomalacia. Lyles KW; Clark AG; Drezner MK Calcif Tissue Int; 1982 Mar; 34(2):125-30. PubMed ID: 6282408 [TBL] [Abstract][Full Text] [Related]
14. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol. Harrell RM; Lyles KW; Harrelson JM; Friedman NE; Drezner MK J Clin Invest; 1985 Jun; 75(6):1858-68. PubMed ID: 3839245 [TBL] [Abstract][Full Text] [Related]
15. Specific internalization and action of 1,25-dihydroxyvitamin D3 in cultured dermal fibroblasts from patients with X-linked hypophosphatemia. Adams JS; Gacad MA; Singer FR J Clin Endocrinol Metab; 1984 Sep; 59(3):556-60. PubMed ID: 6547728 [TBL] [Abstract][Full Text] [Related]
16. Abnormal binding of vitamin D receptors to deoxyribonucleic acid in a kindred with vitamin D-dependent rickets, type II. Malloy PJ; Hochberg Z; Pike JW; Feldman D J Clin Endocrinol Metab; 1989 Feb; 68(2):263-9. PubMed ID: 2537329 [TBL] [Abstract][Full Text] [Related]
17. Effects of therapy in X-linked hypophosphatemic rickets. Verge CF; Lam A; Simpson JM; Cowell CT; Howard NJ; Silink M N Engl J Med; 1991 Dec; 325(26):1843-8. PubMed ID: 1660098 [TBL] [Abstract][Full Text] [Related]
18. X-linked hypophosphatemic rickets and the murine Hyp homologue. Hruska KA; Rifas L; Cheng SL; Gupta A; Halstead L; Avioli L Am J Physiol; 1995 Mar; 268(3 Pt 2):F357-62. PubMed ID: 7900834 [TBL] [Abstract][Full Text] [Related]
19. Evidence suggesting hyperoxaluria as a cause of nephrocalcinosis in phosphate-treated hypophosphataemic rickets. Reusz GS; Latta K; Hoyer PF; Byrd DJ; Ehrich JH; Brodehl J Lancet; 1990 May; 335(8700):1240-3. PubMed ID: 1971321 [TBL] [Abstract][Full Text] [Related]
20. Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets. Glorieux FH; Marie PJ; Pettifor JM; Delvin EE N Engl J Med; 1980 Oct; 303(18):1023-31. PubMed ID: 6252463 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]